EGFR and non-small cell lung carcinoma: Examples of increased killing efficiency include radiosensitization of glioblastoma using temozolomide (DNA alkylating agent) [50], prostate cancer using gefitinib (EGFR inhibitor) [51], and non-small-cell lung cancer (NSCLC) using paclitaxel (mitotic inhibitor) [46,52,53].